SYMPOSIUM: Ex-Vivo Lung Perfusion (EVLP) in 2019: From Research to Implementation

Apr 4, 2019 10:15am ‐ Apr 4, 2019 12:00pm


Description

Implementation of High Volume Clinical EVLP: The Toronto Model
Shaf Keshavjee, MD, FRCSC

Rationale for Portable EVLP
Wiebke Sommer, MD

Benefits and Barriers of a Do-It-Yourself EVLP Program
Peter Hopkins, FRACP

Organ Procurement Organization-Based EVLP Program
Duane Davis, MD, MBA

Experience with a Third-Party EVLP Program
Kenneth McCurry, MD, FACS

The Role of Biomarkers in EVLP
Andrew Fisher, FRCP, PhD

Speaker(s):

  • Shaf Keshavjee, MD, FRCSC, Toronto General Hospital, Toronto, ON, Canada
  • Wiebke Sommer, MD, Hannover Medical School, Hannover, Germany
  • Peter M. Hopkins, FRACP, Prince Charles Hospital, Brisbane, Australia
  • Duane Davis, MD, MBA, Florida Hospital Orlando, FL, USA
  • Kenneth McCurry, MD, FACS, Cleveland Clinic, Cleveland, OH, United States
  • Andrew Fisher, FRCP, PhD, Freeman Hospital, Newcastle Upon Tyne, United Kingdom
Tags: MCS LF-LTX

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
* - Indicates answer is required.
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content